233 related articles for article (PubMed ID: 3622018)
1. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
Fisher J; Mack RJ; Likier HM; Schiff AN; Borer JS
Chest; 1987 Sep; 92(3):400-5. PubMed ID: 3622018
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
[TBL] [Abstract][Full Text] [Related]
3. Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon.
Creager MA; Pariser KM; Winston EM; Rasmussen HM; Miller KB; Coffman JD
Am Heart J; 1984 Aug; 108(2):370-3. PubMed ID: 6380254
[TBL] [Abstract][Full Text] [Related]
4. Use of nifedipine in hypertension and Raynaud's phenomenon.
Kiowski W; Erne P; Bühler FR
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():935-40. PubMed ID: 2076403
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension.
Cockrill BA; Kacmarek RM; Fifer MA; Bigatello LM; Ginns LC; Zapol WM; Semigran MJ
Chest; 2001 Jan; 119(1):128-36. PubMed ID: 11157594
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis.
Shuck JW; Oetgen WJ; Tesar JT
Am J Med; 1985 Feb; 78(2):221-7. PubMed ID: 3970048
[TBL] [Abstract][Full Text] [Related]
8. Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects.
Wollersheim H; Thien T; van 't Laar A
J Clin Pharmacol; 1987 Nov; 27(11):907-13. PubMed ID: 3429697
[TBL] [Abstract][Full Text] [Related]
9. The concept of Raynaud's phenomenon of the lung revisited.
Lampert E; Charloux A; Lonsdorfer J; Frans A
Am J Med; 1996 Nov; 101(5):468-71. PubMed ID: 8948269
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
[TBL] [Abstract][Full Text] [Related]
11. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
[TBL] [Abstract][Full Text] [Related]
12. Syncope and Raynaud's disease.
Guiloff RJ; Rajakulendran S; Angus-Leppan H
Arch Neurol; 2012 May; 69(5):608-13. PubMed ID: 22248476
[TBL] [Abstract][Full Text] [Related]
13. Effects of nifedipine therapy on pulmonary Raynaud's in primary Sjögren's syndrome.
Joseph BZ; Organek HW; Grant A; Axelrod DA
Clin Exp Rheumatol; 1988; 6(4):409-10. PubMed ID: 3229032
[TBL] [Abstract][Full Text] [Related]
14. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
Anderson JE; Held N; Wright K
Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
[TBL] [Abstract][Full Text] [Related]
15. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
Vayssairat M; Blaison N; Baudot N; Evenou P; Gilard M; Mathieu JF
J Mal Vasc; 1989; 14(4):299-302. PubMed ID: 2584886
[TBL] [Abstract][Full Text] [Related]
16. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M
Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066
[TBL] [Abstract][Full Text] [Related]
17. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
Ettinger WH; Wise RA; Schaffhauser D; Wigley FM
Am J Med; 1984 Sep; 77(3):451-6. PubMed ID: 6540986
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
[TBL] [Abstract][Full Text] [Related]
19. [Long-term effects of sildenafil in a patient with scleroderma-associated pulmonary hypertension and Raynaud's syndrome].
Rosenkranz S; Caglayan E; Diet F; Karasch T; Weihrauch J; Wassermann K; Erdmann E
Dtsch Med Wochenschr; 2004 Aug; 129(33):1736-40. PubMed ID: 15295684
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Raynaud's phenomenon with calcium channel blockers.
Smith CR; Rodeheffer RJ
Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
